BIOTECH INSIGHTS

Stemline Therapeutics Acquired by Menarini Group for $677 Million

Headquartered in New York City, small cap biotechnology company Stemline Therapeutics (NASDAQ: STML) has announced that it is being acquired by Italian pharmaceutical company...

BIOTECH NEWS

New Capricor Data Reports 100 Percent Survival in Critical COVID-19 Patients...

U.S. FDA Approves Company’s Expanded Access Protocol to Treat Additional Patients LOS ANGELES, April 29, 2020 (GLOBE NEWSWIRE) -- Capricor Therapeutics (“Capricor”) (NASDAQ: CAPR) a...

ImmunoGen Announces Webcast of Presentation at Upcoming RBC Capital Markets Global...

WALTHAM, Mass.--(BUSINESS WIRE)-- ImmunoGen, Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced...
Advertisement

CEO INTERVIEWS

BiotechStocktrader Interview with Nader Pourhassan, CEO of Cytodyn, Inc.

In this episode of Biotech Stocktrader, we are joined by Dr. Nader Pourhassan, President and CEO of CytoDyn, a biotechnology company developing innovative treatments...

BiotechStocktrader Interview with Dr. Carl Schwartz, CEO of Precision Therapeutics, (AIPT).

In this episode of BiotechStocktrader we are joined by Dr. Carl Schwartz, CEO of Precision Therapeutics, ticker AIPT. About Precision Therapeutics Inc. Precision Therapeutics (AIPT)...
381cf01438895cab0b3756fba2d0131142708ac5e7aa3f1832